Bioscience Trends

Papers
(The H4-Index of Bioscience Trends is 18. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-08-01 to 2025-08-01.)
ArticleCitations
Corrigendum to "Shufengjiedu capsules protect against neuronal loss in olfactory epithelium and lung injury by enhancing autophagy in rats with allergic rhinitis", BioScience Trends. 2019; 13(6):530-5259
Multimodal optimal matching and augmentation method for small sample gesture recognition146
Feasibility of novel intraoperative navigation for anatomical liver resection using real-time virtual sonography combined with indocyanine green fluorescent imaging technology105
New progress in elucidating the relationship between cancer therapy and cardiovascular toxicity73
Therapeutic potentials of mesenchymal stem cell-derived exosomes for major solid malignancies: A narrative systematic review55
Formulation and interpretation of the Chinese Guidelines for Surgical Treatment of Obesity and Type 2 Diabetes Mellitus54
Integration of wearable devices and deep learning: New possibilities for health management and disease prevention35
Exploring the multiple therapeutic mechanisms and challenges of mesenchymal stem cell-derived exosomes in Alzheimer's disease34
The management of dementia worldwide: A review on policy practices, clinical guidelines, end-of-life care, and challenge along with aging population31
Neoadjuvant therapy <i>vs</i>. upfront surgery for resectable pancreatic cancer: An update on a systematic review and meta-analysis27
Trends in the treatment of advanced pancreatic cancer27
Deep cervical lymphaticovenous anastomosis in Alzheimer's disease: A promising frontier or premature enthusiasm?27
Advances in research on receptor heterogeneity in breast cancer liver metastasis26
Strengthening medical facility responses to respiratory infectious diseases: Global trends, challenges, and innovations post-COVID-1925
Advances in systemic therapy leading to conversion surgery for advanced hepatocellular carcinoma24
Liver transplantation for patients with hepatocellular carcinoma: Its current status and advances20
Conversion therapy followed by surgery and adjuvant therapy improves survival in Barcelona C stage hepatocellular carcinoma ― A propensity score-matched analysis19
Donor-recipient matching in adult liver transplantation: Current status and advances19
Opportunities and challenges to the use of neutralizing monoclonal antibody therapies for COVID-1918
NAD(P)H-quinone oxidoreductase 1 induces complicated effects on mitochondrial dysfunction and ferroptosis in an expression level-dependent manner18
0.033541917800903